Deutsch English Français

Contact

EP1795192

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1795192

EP1795192 - 1-(Pyridazin-3-yl)-imidazole derivatives as inhibitors of nitric oxide synthase (NOS) [Right-click to bookmark this link]
Former [2007/24]	1-Substituted imidazole derivatives as nos inhibitors
	[2007/25]
Status	The application is deemed to be withdrawn Status updated on 22.03.2013 Database last updated on 15.06.2024
Most recent event Tooltip	22.03.2013	Application deemed to be withdrawn	published on 24.04.2013 [2013/17]
Applicant(s)	For all designated states Bayer Pharma Aktiengesellschaft Müllerstrasse 178 13353 Berlin / DE
	[2011/34]
Former [2007/24]	For all designated states Bayer Schering Pharma Aktiengesellschaft Müllerstrasse 178 13353 Berlin / DE
Inventor(s)	01 / Davey, David D. 3813 Painted Pony Road El Sobrante CA California 94803 / US
	02 / Mohan, Raju 3125 Caminito Ricardo Encinitis CA California 92024 / US
	03 / Phillips, Gary B. 3034 Shetland Drive Pleasant Hill CA California 94523 / US
	04 / Wei, Guo Ping 326 Langton Court San Ramon CA 94549 / US
	05 / Xu, Wei 327 Glasgow Circle Danville CA California 94526 / US
	[2007/33]
Former [2007/24]	01 / Davey, David D. 3813 Painted Pony Road El Sobrante CA California 94803 / US
	02 / Mohan, Raju 3125 Caminito Ricardo Encinitis CA California 92024 / US
	03 / Phillips, Gary B. 3034 Shetland Drive Pleasant Hill CA California 94523 / US
	04 / Wei, Guo Ping 1105 Vista Point Circle San Ramon CA California 94543 / US
	05 / Xu, Wei 327 Glasgow Circle Danville CA California 94526 / US
Representative(s)	Pohlman, Sandra M. df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE
	[N/P]
Former [2008/41]	Pohlman, Sandra M. df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE
Former [2007/24]	Pohlman, Sandra M. df-mp, Dörries, Frank-Molnia & Pohlman, Triftstrasse 13 80538 München / DE
Application number, filing date	07002234.8	24.04.2003
	[2007/24]
Priority number, date	US20020377274P	30.04.2002 Original published format: US 377274 P
	[2007/24]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP1795192
	Date:	13.06.2007
	Language:	EN
	[2007/24]
	Type:	A3 Search report
	No.:	EP1795192
	Date:	07.05.2008
	[2008/19]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	09.04.2008
Classification	IPC:	A61K31/415, A61K31/50, A61P19/02, C07D405/14, C07D401/12, C07D405/12	[2007/24]
	CPC:	C07D405/14 (EP); A61P1/04 (EP); A61P11/00 (EP); A61P11/06 (EP); A61P13/12 (EP); A61P17/00 (EP); (+) A61P17/02 (EP); A61P17/06 (EP); A61P19/02 (EP); A61P25/00 (EP); A61P25/16 (EP); A61P25/28 (EP); A61P3/10 (EP); A61P31/00 (EP); A61P35/00 (EP); A61P37/02 (EP); A61P37/06 (EP); A61P9/04 (EP); A61P9/10 (EP); A61P9/12 (EP); C07D401/12 (EP); C07D401/14 (EP); C07D405/12 (EP) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2007/24]
Title	German:	1-(pyridazin-3-yl)-Imidazol Derivaten als NO-Synthase (NOS) Hemmer	[2007/25]
	English:	1-(Pyridazin-3-yl)-imidazole derivatives as inhibitors of nitric oxide synthase (NOS)	[2007/25]
	French:	Dérivés de 1-(pyridazin-3-yl)-imidazole utiles comme inhibiteurs de la synthase d'oxyde nitrique (NOS)	[2007/25]
	Former [2007/24]	1-Substitutierten Imidazol Derivaten als Nos Inhibitoren
	Former [2007/24]	1-Substituted imidazole derivatives as nos inhibitors
	Former [2007/24]	Derives de l'imidazole 1-substitues comme inhibiteurs nos
Examination procedure	18.09.2008	Examination requested [2008/44]
	28.10.2008	Despatch of a communication from the examining division (Time limit: M06)
	27.04.2009	Reply to a communication from the examining division
	19.05.2009	Despatch of a communication from the examining division (Time limit: M04)
	28.09.2009	Reply to a communication from the examining division
	20.12.2010	Despatch of a communication from the examining division (Time limit: M04)
	20.04.2011	Reply to a communication from the examining division
	01.11.2012	Application deemed to be withdrawn, date of legal effect [2013/17]
	07.12.2012	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/17]
Parent application(s) Tooltip	EP03726440.5 / EP1501504
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030726440) is 03.03.2005
Fees paid	Renewal fee
	01.02.2007	Renewal fee patent year 03
	01.02.2007	Renewal fee patent year 04
	01.02.2007	Renewal fee patent year 05
	19.03.2008	Renewal fee patent year 06
	16.04.2009	Renewal fee patent year 07
	02.11.2010	Renewal fee patent year 08
	02.05.2011	Renewal fee patent year 09
	Penalty fee
	Additional fee for renewal fee
	30.04.2010	08 M06 Fee paid on 02.11.2010
	30.04.2012	10 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]EP0306440 (SCHERING AG [DE]) [X] 1,7,9 * examples 4,6-8,10,22 *;
		[X]EP0757988 (NIPPON SODA CO [JP]) [X] 1,7,9 * example n (1-66) Table 2, p. 39;; claim 1 *;
		[A]WO9837079 (BERLEX LAB [US], et al) [A] 1-13* compounds (IIh) p.59 and (IIk) p.61;; claim 1 *;
		[A]WO0114371 (BERLEX LAB [US], et al) [A] 1-13 * compound p.10;; claim 1 *;
		[A]WO0172744 (SCHERING AG [DE], et al) [A] 1-13 * claim 1 *;
		[X]WO0212190 (ORTHO MCNEIL PHARM INC [US]) [X] 1,7 * examples 6,33,34,78 *;
		[X]WO0232897 (PFIZER PROD INC [US], et al) [X] 1,7 * example 32 *;
		[X] - LIS, RANDALL ET AL, "Synthesis of novel (aryloxy)propanolamines and related compounds possessing both class II and class III antiarrhythmic activity", JOURNAL OF MEDICINAL CHEMISTRY , 33(10), 2883-91, (1990), XP002089081 [X] 1,7 * scheme V, ex. 34, 36 * DOI: http://dx.doi.org/10.1021/jm00172a033

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p